APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spatial Omics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Spatial Omics Market Analysis and Forecast 2026-2032

31 December 2025206 pages

Choose your research edition.

Industry ResearchSpatial Omics Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Spatial Omics Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Spatial Omics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spatial Omics Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Spatial Omics Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Spatial Omics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Spatial Omics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Spatial Omics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Spatial Omics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Spatial Omics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Spatial Omics include Akoya Biosciences, Biognosys AG, BioSpyder Technologies, Bio-Techne, Brooks Automation, Bruker Corporation, Danaher Corporation, Diagenode Diagnostics and Dovetail Genomics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Spatial Omics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Spatial Omics, also provides the revenue of main regions and countries. Of the upcoming market potential for Spatial Omics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Spatial Omics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Spatial Omics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Spatial Omics revenue, projected growth trends, production technology, application and end-user industry.

Spatial Omics Segment by Company

Akoya Biosciences

Biognosys AG

BioSpyder Technologies

Bio-Techne

Brooks Automation

Bruker Corporation

Danaher Corporation

Diagenode Diagnostics

Dovetail Genomics

IonPath

Nanostring Technologies

PerkinElmer

Rebus Biosystems

S2 Genomics

Seven Bridges Genomics

Vizgen Corporation

Spatial Omics Segment by Type

Spatial Transcriptomic

Spatial Genomics

Spatial Proteomics

Spatial Omics Segment by Application

Laboratory

Research Institutions

Other

Spatial Omics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Omics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spatial Omics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Omics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Spatial Omics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Spatial Omics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spatial Omics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Spatial Omics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Spatial Transcriptomic Major Player Table 3. Spatial Genomics Major Player Table 4. Spatial Proteomics Major Player Table 5. Global Spatial Omics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Laboratory Major Player Table 7. Research Institutions Major Player Table 8. Other Major Player Table 9. Spatial Omics Industry Trends Table 10. Spatial Omics Industry Drivers Table 11. Spatial Omics Industry Opportunities and Challenges Table 12. Spatial Omics Industry Restraints Table 13. Global Spatial Omics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Spatial Omics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Spatial Omics Market Share by Region (2021-2026) Table 16. Global Spatial Omics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Spatial Omics Market Share by Region (2027-2032) Table 18. Global Spatial Omics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Spatial Omics Revenue Market Share by Players (2021-2026) Table 20. Global Spatial Omics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Spatial Omics Key Players Headquarters & Area Served Table 22. Global Spatial Omics Players, Product Type & Application Table 23. Global Spatial Omics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Spatial Omics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Spatial Omics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Spatial Omics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Spatial Omics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Spatial Omics Revenue Market Share by Type (2021-2026) Table 30. Global Spatial Omics Revenue Market Share by Type (2027-2032) Table 31. Global Spatial Omics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Spatial Omics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Spatial Omics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Spatial Omics Revenue Market Share by Application (2021-2026) Table 35. Global Spatial Omics Revenue Market Share by Application (2027-2032) Table 36. Akoya Biosciences Company Information Table 37. Akoya Biosciences Business Overview Table 38. Akoya Biosciences Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Akoya Biosciences Spatial Omics Product Portfolio Table 40. Akoya Biosciences Recent Development Table 41. Biognosys AG Company Information Table 42. Biognosys AG Business Overview Table 43. Biognosys AG Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Biognosys AG Spatial Omics Product Portfolio Table 45. Biognosys AG Recent Development Table 46. BioSpyder Technologies Company Information Table 47. BioSpyder Technologies Business Overview Table 48. BioSpyder Technologies Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. BioSpyder Technologies Spatial Omics Product Portfolio Table 50. BioSpyder Technologies Recent Development Table 51. Bio-Techne Company Information Table 52. Bio-Techne Business Overview Table 53. Bio-Techne Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bio-Techne Spatial Omics Product Portfolio Table 55. Bio-Techne Recent Development Table 56. Brooks Automation Company Information Table 57. Brooks Automation Business Overview Table 58. Brooks Automation Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Brooks Automation Spatial Omics Product Portfolio Table 60. Brooks Automation Recent Development Table 61. Bruker Corporation Company Information Table 62. Bruker Corporation Business Overview Table 63. Bruker Corporation Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Bruker Corporation Spatial Omics Product Portfolio Table 65. Bruker Corporation Recent Development Table 66. Danaher Corporation Company Information Table 67. Danaher Corporation Business Overview Table 68. Danaher Corporation Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Danaher Corporation Spatial Omics Product Portfolio Table 70. Danaher Corporation Recent Development Table 71. Diagenode Diagnostics Company Information Table 72. Diagenode Diagnostics Business Overview Table 73. Diagenode Diagnostics Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Diagenode Diagnostics Spatial Omics Product Portfolio Table 75. Diagenode Diagnostics Recent Development Table 76. Dovetail Genomics Company Information Table 77. Dovetail Genomics Business Overview Table 78. Dovetail Genomics Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Dovetail Genomics Spatial Omics Product Portfolio Table 80. Dovetail Genomics Recent Development Table 81. IonPath Company Information Table 82. IonPath Business Overview Table 83. IonPath Spatial Omics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. IonPath Spatial Omics Product Portfolio Table 85. IonPath Recent Development Table 86. Nanostring Technologies Company Information Table 87. Nanostring Technologies Business Overview Table 88. Nanostring Technologies Spatial Omics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Nanostring Technologies Spatial Omics Product Portfolio Table 90. Nanostring Technologies Recent Development Table 91. PerkinElmer Company Information Table 92. PerkinElmer Business Overview Table 93. PerkinElmer Spatial Omics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. PerkinElmer Spatial Omics Product Portfolio Table 95. PerkinElmer Recent Development Table 96. Rebus Biosystems Company Information Table 97. Rebus Biosystems Business Overview Table 98. Rebus Biosystems Spatial Omics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Rebus Biosystems Spatial Omics Product Portfolio Table 100. Rebus Biosystems Recent Development Table 101. S2 Genomics Company Information Table 102. S2 Genomics Business Overview Table 103. S2 Genomics Spatial Omics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. S2 Genomics Spatial Omics Product Portfolio Table 105. S2 Genomics Recent Development Table 106. Seven Bridges Genomics Company Information Table 107. Seven Bridges Genomics Business Overview Table 108. Seven Bridges Genomics Spatial Omics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Seven Bridges Genomics Spatial Omics Product Portfolio Table 110. Seven Bridges Genomics Recent Development Table 111. Vizgen Corporation Company Information Table 112. Vizgen Corporation Business Overview Table 113. Vizgen Corporation Spatial Omics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Vizgen Corporation Spatial Omics Product Portfolio Table 115. Vizgen Corporation Recent Development Table 116. North America Spatial Omics Revenue by Type (2021-2026) & (US$ Million) Table 117. North America Spatial Omics Revenue by Type (2027-2032) & (US$ Million) Table 118. North America Spatial Omics Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Spatial Omics Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Spatial Omics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Spatial Omics Revenue by Country (2021-2026) & (US$ Million) Table 122. North America Spatial Omics Revenue by Country (US$ Million) & (2027-2032) Table 123. Europe Spatial Omics Revenue by Type (2021-2026) & (US$ Million) Table 124. Europe Spatial Omics Revenue by Type (2027-2032) & (US$ Million) Table 125. Europe Spatial Omics Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Spatial Omics Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Spatial Omics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Spatial Omics Revenue by Country (2021-2026) & (US$ Million) Table 129. Europe Spatial Omics Revenue by Country (US$ Million) & (2027-2032) Table 130. China Spatial Omics Revenue by Type (2021-2026) & (US$ Million) Table 131. China Spatial Omics Revenue by Type (2027-2032) & (US$ Million) Table 132. China Spatial Omics Revenue by Application (2021-2026) & (US$ Million) Table 133. China Spatial Omics Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Spatial Omics Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia Spatial Omics Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia Spatial Omics Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia Spatial Omics Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Spatial Omics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Spatial Omics Revenue by Region (US$ Million) & (2021-2026) Table 140. Asia Spatial Omics Revenue by Region (US$ Million) & (2027-2032) Table 141. SAMEA Spatial Omics Revenue by Type (2021-2026) & (US$ Million) Table 142. SAMEA Spatial Omics Revenue by Type (2027-2032) & (US$ Million) Table 143. SAMEA Spatial Omics Revenue by Application (2021-2026) & (US$ Million) Table 144. SAMEA Spatial Omics Revenue by Application (2027-2032) & (US$ Million) Table 145. SAMEA Spatial Omics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. SAMEA Spatial Omics Revenue by Country (2021-2026) & (US$ Million) Table 147. SAMEA Spatial Omics Revenue by Country (US$ Million) & (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Spatial Omics Image Figure 2. Global Spatial Omics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spatial Omics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Spatial Transcriptomic Image Figure 5. Spatial Genomics Image Figure 6. Spatial Proteomics Image Figure 7. Global Spatial Omics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Spatial Omics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Laboratory Image Figure 10. Research Institutions Image Figure 11. Other Image Figure 12. Global Spatial Omics Market Size (US$ Million) & (2021-2032) Figure 13. Global Spatial Omics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Spatial Omics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Spatial Omics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Spatial Omics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Spatial Omics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Spatial Omics Revenue Market Share by Type (2021-2032) Figure 20. Global Spatial Omics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Spatial Omics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Spatial Omics Revenue Market Share by Application (2021-2032) Figure 23. North America Spatial Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Spatial Omics Revenue Share by Type (2021-2032) Figure 25. North America Spatial Omics Revenue Share by Application (2021-2032) Figure 26. North America Spatial Omics Revenue Share by Country (2021-2032) Figure 27. United States Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Spatial Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Spatial Omics Revenue Share by Type (2021-2032) Figure 32. Europe Spatial Omics Revenue Share by Application (2021-2032) Figure 33. Europe Spatial Omics Revenue Share by Country (2021-2032) Figure 34. Germany Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Spatial Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Spatial Omics Revenue Share by Type (2021-2032) Figure 44. China Spatial Omics Revenue Share by Application (2021-2032) Figure 45. Asia Spatial Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Spatial Omics Revenue Share by Type (2021-2032) Figure 47. Asia Spatial Omics Revenue Share by Application (2021-2032) Figure 48. Asia Spatial Omics Revenue Share by Region (2021-2032) Figure 49. Japan Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Spatial Omics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Spatial Omics Revenue Share by Type (2021-2032) Figure 57. SAMEA Spatial Omics Revenue Share by Application (2021-2032) Figure 58. SAMEA Spatial Omics Revenue Share by Country (2021-2032) Figure 59. Brazil Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Spatial Omics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Spatial Transcriptomic
  • Spatial Genomics
  • Spatial Proteomics
Applications
  • Laboratory
  • Research Institutions
  • Other
Companies covered
  • Akoya Biosciences
  • Biognosys AG
  • BioSpyder Technologies
  • Bio-Techne
  • Brooks Automation
  • Bruker Corporation
  • Danaher Corporation
  • Diagenode Diagnostics
  • Dovetail Genomics
  • IonPath
  • Nanostring Technologies
  • PerkinElmer
  • Rebus Biosystems
  • S2 Genomics
  • Seven Bridges Genomics
  • Vizgen Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Spatial Omics Market by Type
  3. 1.2.1 Global Spatial Omics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Spatial Transcriptomic
  5. 1.2.3 Spatial Genomics
  6. 1.2.4 Spatial Proteomics
  7. 1.3 Spatial Omics Market by Application
  8. 1.3.1 Global Spatial Omics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Laboratory
  10. 1.3.3 Research Institutions
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Spatial Omics Market Dynamics
  1. 2.1 Spatial Omics Industry Trends
  2. 2.2 Spatial Omics Industry Drivers
  3. 2.3 Spatial Omics Industry Opportunities and Challenges
  4. 2.4 Spatial Omics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Spatial Omics Market Perspective (2021-2032)
  2. 3.2 Global Spatial Omics Growth Trends by Region
  3. 3.2.1 Global Spatial Omics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Spatial Omics Market Size by Region (2021-2026)
  5. 3.2.3 Global Spatial Omics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Spatial Omics Revenue by Players
  2. 4.1.1 Global Spatial Omics Revenue by Players (2021-2026)
  3. 4.1.2 Global Spatial Omics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Spatial Omics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Spatial Omics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Spatial Omics Key Players Headquarters & Area Served
  7. 4.4 Global Spatial Omics Players, Product Type & Application
  8. 4.5 Global Spatial Omics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Spatial Omics Market CR5 and HHI
  11. 4.6.3 2025 Spatial Omics Tier 1, Tier 2, and Tier 3
5 Spatial Omics Market Size by Type
  1. 5.1 Global Spatial Omics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Spatial Omics Revenue by Type (2021-2032)
  3. 5.3 Global Spatial Omics Revenue Market Share by Type (2021-2032)
6 Spatial Omics Market Size by Application
  1. 6.1 Global Spatial Omics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Spatial Omics Revenue by Application (2021-2032)
  3. 6.3 Global Spatial Omics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Akoya Biosciences
  2. 7.1.1 Akoya Biosciences Company Information
  3. 7.1.2 Akoya Biosciences Business Overview
  4. 7.1.3 Akoya Biosciences Spatial Omics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Akoya Biosciences Spatial Omics Product Portfolio
  6. 7.1.5 Akoya Biosciences Recent Developments
  7. 7.2 Biognosys AG
  8. 7.2.1 Biognosys AG Company Information
  9. 7.2.2 Biognosys AG Business Overview
  10. 7.2.3 Biognosys AG Spatial Omics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biognosys AG Spatial Omics Product Portfolio
  12. 7.2.5 Biognosys AG Recent Developments
  13. 7.3 BioSpyder Technologies
  14. 7.3.1 BioSpyder Technologies Company Information
  15. 7.3.2 BioSpyder Technologies Business Overview
  16. 7.3.3 BioSpyder Technologies Spatial Omics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BioSpyder Technologies Spatial Omics Product Portfolio
  18. 7.3.5 BioSpyder Technologies Recent Developments
  19. 7.4 Bio-Techne
  20. 7.4.1 Bio-Techne Company Information
  21. 7.4.2 Bio-Techne Business Overview
  22. 7.4.3 Bio-Techne Spatial Omics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bio-Techne Spatial Omics Product Portfolio
  24. 7.4.5 Bio-Techne Recent Developments
  25. 7.5 Brooks Automation
  26. 7.5.1 Brooks Automation Company Information
  27. 7.5.2 Brooks Automation Business Overview
  28. 7.5.3 Brooks Automation Spatial Omics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Brooks Automation Spatial Omics Product Portfolio
  30. 7.5.5 Brooks Automation Recent Developments
  31. 7.6 Bruker Corporation
  32. 7.6.1 Bruker Corporation Company Information
  33. 7.6.2 Bruker Corporation Business Overview
  34. 7.6.3 Bruker Corporation Spatial Omics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bruker Corporation Spatial Omics Product Portfolio
  36. 7.6.5 Bruker Corporation Recent Developments
  37. 7.7 Danaher Corporation
  38. 7.7.1 Danaher Corporation Company Information
  39. 7.7.2 Danaher Corporation Business Overview
  40. 7.7.3 Danaher Corporation Spatial Omics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Danaher Corporation Spatial Omics Product Portfolio
  42. 7.7.5 Danaher Corporation Recent Developments
  43. 7.8 Diagenode Diagnostics
  44. 7.8.1 Diagenode Diagnostics Company Information
  45. 7.8.2 Diagenode Diagnostics Business Overview
  46. 7.8.3 Diagenode Diagnostics Spatial Omics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Diagenode Diagnostics Spatial Omics Product Portfolio
  48. 7.8.5 Diagenode Diagnostics Recent Developments
  49. 7.9 Dovetail Genomics
  50. 7.9.1 Dovetail Genomics Company Information
  51. 7.9.2 Dovetail Genomics Business Overview
  52. 7.9.3 Dovetail Genomics Spatial Omics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Dovetail Genomics Spatial Omics Product Portfolio
  54. 7.9.5 Dovetail Genomics Recent Developments
  55. 7.10 IonPath
  56. 7.10.1 IonPath Company Information
  57. 7.10.2 IonPath Business Overview
  58. 7.10.3 IonPath Spatial Omics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 IonPath Spatial Omics Product Portfolio
  60. 7.10.5 IonPath Recent Developments
  61. 7.11 Nanostring Technologies
  62. 7.11.1 Nanostring Technologies Company Information
  63. 7.11.2 Nanostring Technologies Business Overview
  64. 7.11.3 Nanostring Technologies Spatial Omics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Nanostring Technologies Spatial Omics Product Portfolio
  66. 7.11.5 Nanostring Technologies Recent Developments
  67. 7.12 PerkinElmer
  68. 7.12.1 PerkinElmer Company Information
  69. 7.12.2 PerkinElmer Business Overview
  70. 7.12.3 PerkinElmer Spatial Omics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 PerkinElmer Spatial Omics Product Portfolio
  72. 7.12.5 PerkinElmer Recent Developments
  73. 7.13 Rebus Biosystems
  74. 7.13.1 Rebus Biosystems Company Information
  75. 7.13.2 Rebus Biosystems Business Overview
  76. 7.13.3 Rebus Biosystems Spatial Omics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Rebus Biosystems Spatial Omics Product Portfolio
  78. 7.13.5 Rebus Biosystems Recent Developments
  79. 7.14 S2 Genomics
  80. 7.14.1 S2 Genomics Company Information
  81. 7.14.2 S2 Genomics Business Overview
  82. 7.14.3 S2 Genomics Spatial Omics Revenue and Gross Margin (2021-2026)
  83. 7.14.4 S2 Genomics Spatial Omics Product Portfolio
  84. 7.14.5 S2 Genomics Recent Developments
  85. 7.15 Seven Bridges Genomics
  86. 7.15.1 Seven Bridges Genomics Company Information
  87. 7.15.2 Seven Bridges Genomics Business Overview
  88. 7.15.3 Seven Bridges Genomics Spatial Omics Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Seven Bridges Genomics Spatial Omics Product Portfolio
  90. 7.15.5 Seven Bridges Genomics Recent Developments
  91. 7.16 Vizgen Corporation
  92. 7.16.1 Vizgen Corporation Company Information
  93. 7.16.2 Vizgen Corporation Business Overview
  94. 7.16.3 Vizgen Corporation Spatial Omics Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Vizgen Corporation Spatial Omics Product Portfolio
  96. 7.16.5 Vizgen Corporation Recent Developments
8 North America
  1. 8.1 North America Spatial Omics Revenue (2021-2032)
  2. 8.2 North America Spatial Omics Revenue by Type (2021-2032)
  3. 8.2.1 North America Spatial Omics Revenue by Type (2021-2026)
  4. 8.2.2 North America Spatial Omics Revenue by Type (2027-2032)
  5. 8.3 North America Spatial Omics Revenue Share by Type (2021-2032)
  6. 8.4 North America Spatial Omics Revenue by Application (2021-2032)
  7. 8.4.1 North America Spatial Omics Revenue by Application (2021-2026)
  8. 8.4.2 North America Spatial Omics Revenue by Application (2027-2032)
  9. 8.5 North America Spatial Omics Revenue Share by Application (2021-2032)
  10. 8.6 North America Spatial Omics Revenue by Country
  11. 8.6.1 North America Spatial Omics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Spatial Omics Revenue by Country (2021-2026)
  13. 8.6.3 North America Spatial Omics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Spatial Omics Revenue (2021-2032)
  2. 9.2 Europe Spatial Omics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Spatial Omics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Spatial Omics Revenue by Type (2027-2032)
  5. 9.3 Europe Spatial Omics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Spatial Omics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Spatial Omics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Spatial Omics Revenue by Application (2027-2032)
  9. 9.5 Europe Spatial Omics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Spatial Omics Revenue by Country
  11. 9.6.1 Europe Spatial Omics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Spatial Omics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Spatial Omics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Spatial Omics Revenue (2021-2032)
  2. 10.2 China Spatial Omics Revenue by Type (2021-2032)
  3. 10.2.1 China Spatial Omics Revenue by Type (2021-2026)
  4. 10.2.2 China Spatial Omics Revenue by Type (2027-2032)
  5. 10.3 China Spatial Omics Revenue Share by Type (2021-2032)
  6. 10.4 China Spatial Omics Revenue by Application (2021-2032)
  7. 10.4.1 China Spatial Omics Revenue by Application (2021-2026)
  8. 10.4.2 China Spatial Omics Revenue by Application (2027-2032)
  9. 10.5 China Spatial Omics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Spatial Omics Revenue (2021-2032)
  2. 11.2 Asia Spatial Omics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Spatial Omics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Spatial Omics Revenue by Type (2027-2032)
  5. 11.3 Asia Spatial Omics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Spatial Omics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Spatial Omics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Spatial Omics Revenue by Application (2027-2032)
  9. 11.5 Asia Spatial Omics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Spatial Omics Revenue by Country
  11. 11.6.1 Asia Spatial Omics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Spatial Omics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Spatial Omics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Spatial Omics Revenue (2021-2032)
  2. 12.2 SAMEA Spatial Omics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Spatial Omics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Spatial Omics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Spatial Omics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Spatial Omics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Spatial Omics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Spatial Omics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Spatial Omics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Spatial Omics Revenue by Country
  11. 12.6.1 SAMEA Spatial Omics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Spatial Omics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Spatial Omics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst